

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 8.80026990 |
| 2 | * COPI coating of Golgi vesicle (GO:0048205) | 7.88831327 |
| 3 | * Golgi transport vesicle coating (GO:0048200) | 7.88831327 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.02603630 |
| 5 | protein retention in ER lumen (GO:0006621) | 6.41510965 |
| 6 | protein maturation by protein folding (GO:0022417) | 5.43699675 |
| 7 | sequestering of metal ion (GO:0051238) | 5.17645978 |
| 8 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.74092256 |
| 9 | ER overload response (GO:0006983) | 4.69698199 |
| 10 | desmosome organization (GO:0002934) | 4.67340306 |
| 11 | * COPII vesicle coating (GO:0048208) | 4.54293676 |
| 12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.46277087 |
| 13 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.37477212 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 4.36529877 |
| 15 | central nervous system myelination (GO:0022010) | 4.36529877 |
| 16 | positive regulation of nuclease activity (GO:0032075) | 4.30390188 |
| 17 | * retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.14389167 |
| 18 | exocrine pancreas development (GO:0031017) | 4.13129997 |
| 19 | amyloid precursor protein catabolic process (GO:0042987) | 4.07242177 |
| 20 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.04292527 |
| 21 | endocrine pancreas development (GO:0031018) | 4.01420486 |
| 22 | cellular response to unfolded protein (GO:0034620) | 3.97724323 |
| 23 | regulation of nuclease activity (GO:0032069) | 3.94131955 |
| 24 | cell adhesion mediated by integrin (GO:0033627) | 3.92988764 |
| 25 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.90738190 |
| 26 | cellular response to topologically incorrect protein (GO:0035967) | 3.87465414 |
| 27 | nucleotide transmembrane transport (GO:1901679) | 3.87015702 |
| 28 | peptidyl-asparagine modification (GO:0018196) | 3.83858044 |
| 29 | peptide hormone processing (GO:0016486) | 3.80032795 |
| 30 | fatty acid elongation (GO:0030497) | 3.77845249 |
| 31 | amyloid precursor protein metabolic process (GO:0042982) | 3.75979258 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.75293285 |
| 33 | ER-nucleus signaling pathway (GO:0006984) | 3.71777035 |
| 34 | protein N-linked glycosylation (GO:0006487) | 3.70909825 |
| 35 | skin morphogenesis (GO:0043589) | 3.70684906 |
| 36 | hemidesmosome assembly (GO:0031581) | 3.67994316 |
| 37 | GDP-mannose metabolic process (GO:0019673) | 3.54013314 |
| 38 | eosinophil chemotaxis (GO:0048245) | 3.52236439 |
| 39 | keratan sulfate catabolic process (GO:0042340) | 3.48665760 |
| 40 | response to endoplasmic reticulum stress (GO:0034976) | 3.44744070 |
| 41 | regulation of sister chromatid cohesion (GO:0007063) | 3.34390609 |
| 42 | * ER to Golgi vesicle-mediated transport (GO:0006888) | 3.28124105 |
| 43 | glandular epithelial cell differentiation (GO:0002067) | 3.26292630 |
| 44 | peptide catabolic process (GO:0043171) | 3.26136801 |
| 45 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.24137102 |
| 46 | type B pancreatic cell development (GO:0003323) | 3.23526543 |
| 47 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.21870775 |
| 48 | response to unfolded protein (GO:0006986) | 3.21342825 |
| 49 | * vesicle coating (GO:0006901) | 3.21297579 |
| 50 | response to lipoprotein particle (GO:0055094) | 3.19717802 |
| 51 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.17935178 |
| 52 | membrane protein ectodomain proteolysis (GO:0006509) | 3.17383792 |
| 53 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.14953855 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14148266 |
| 55 | response to topologically incorrect protein (GO:0035966) | 3.13190091 |
| 56 | eosinophil migration (GO:0072677) | 3.09067488 |
| 57 | negative regulation of complement activation (GO:0045916) | 3.08916827 |
| 58 | creatine metabolic process (GO:0006600) | 3.05471643 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 3.01252734 |
| 60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.99591103 |
| 61 | surfactant homeostasis (GO:0043129) | 2.97329512 |
| 62 | myelin maintenance (GO:0043217) | 2.96558700 |
| 63 | negative regulation of JUN kinase activity (GO:0043508) | 2.96167313 |
| 64 | magnesium ion transport (GO:0015693) | 2.95562758 |
| 65 | negative regulation of protein activation cascade (GO:2000258) | 2.94198859 |
| 66 | response to redox state (GO:0051775) | 2.94087901 |
| 67 | adhesion of symbiont to host cell (GO:0044650) | 2.93931570 |
| 68 | virion attachment to host cell (GO:0019062) | 2.93931570 |
| 69 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.92831960 |
| 70 | cholesterol biosynthetic process (GO:0006695) | 2.92476429 |
| 71 | cell redox homeostasis (GO:0045454) | 2.89905885 |
| 72 | negative regulation of Ras GTPase activity (GO:0034261) | 2.89579433 |
| 73 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.87873754 |
| 74 | intestinal epithelial cell development (GO:0060576) | 2.86456620 |
| 75 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.85946633 |
| 76 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.85551860 |
| 77 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.85551860 |
| 78 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.85551860 |
| 79 | glycolipid catabolic process (GO:0019377) | 2.85349274 |
| 80 | peptidyl-proline hydroxylation (GO:0019511) | 2.83782327 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.79011108 |
| 82 | regulation of metalloenzyme activity (GO:0048552) | 2.77665264 |
| 83 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.77010715 |
| 84 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.76639049 |
| 85 | regulation of extracellular matrix disassembly (GO:0010715) | 2.76331157 |
| 86 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75937831 |
| 87 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.75163208 |
| 88 | 4-hydroxyproline metabolic process (GO:0019471) | 2.74500197 |
| 89 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.73745236 |
| 90 | glycosylceramide metabolic process (GO:0006677) | 2.71698095 |
| 91 | peptide metabolic process (GO:0006518) | 2.71397004 |
| 92 | toxin metabolic process (GO:0009404) | 2.69534765 |
| 93 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.68983021 |
| 94 | L-serine transport (GO:0015825) | 2.66839572 |
| 95 | adhesion of symbiont to host (GO:0044406) | 2.63189770 |
| 96 | protein hydroxylation (GO:0018126) | 2.62686360 |
| 97 | gap junction assembly (GO:0016264) | 2.62487561 |
| 98 | mannosylation (GO:0097502) | 2.62290278 |
| 99 | apoptotic cell clearance (GO:0043277) | 2.61835645 |
| 100 | ensheathment of neurons (GO:0007272) | 2.61398511 |
| 101 | axon ensheathment (GO:0008366) | 2.61398511 |
| 102 | regulation of phospholipase A2 activity (GO:0032429) | 2.61179043 |
| 103 | branch elongation of an epithelium (GO:0060602) | 2.57533711 |
| 104 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.57493641 |
| 105 | cellular zinc ion homeostasis (GO:0006882) | 2.57259538 |
| 106 | myelination (GO:0042552) | 2.55730716 |
| 107 | sterol biosynthetic process (GO:0016126) | 2.55508431 |
| 108 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.55328407 |
| 109 | ceramide catabolic process (GO:0046514) | 2.55037125 |
| 110 | regulation of complement activation (GO:0030449) | 2.53985281 |
| 111 | nucleoside diphosphate catabolic process (GO:0009134) | 2.52766945 |
| 112 | astrocyte differentiation (GO:0048708) | 2.52157936 |
| 113 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.51502491 |
| 114 | cellular response to vitamin D (GO:0071305) | 2.51329517 |
| 115 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.50816085 |
| 116 | fucose metabolic process (GO:0006004) | 2.50441223 |
| 117 | regulation of cardioblast differentiation (GO:0051890) | 2.50424215 |
| 118 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.49718496 |
| 119 | transcytosis (GO:0045056) | 2.48916751 |
| 120 | regulation of autophagic vacuole assembly (GO:2000785) | 2.47802903 |
| 121 | regulation of protein activation cascade (GO:2000257) | 2.47333846 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 2.46794501 |
| 123 | membrane protein proteolysis (GO:0033619) | 2.46622072 |
| 124 | glomerular basement membrane development (GO:0032836) | 2.46585042 |
| 125 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.46145975 |
| 126 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.45923012 |
| 127 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.44705488 |
| 128 | negative regulation of humoral immune response (GO:0002921) | 2.44585867 |
| 129 | NADH metabolic process (GO:0006734) | 2.44132099 |
| 130 | chondrocyte development (GO:0002063) | 2.43816678 |
| 131 | iron ion import (GO:0097286) | 2.43729561 |
| 132 | nucleotide transport (GO:0006862) | 2.43516593 |
| 133 | eye photoreceptor cell differentiation (GO:0001754) | 2.42766830 |
| 134 | photoreceptor cell differentiation (GO:0046530) | 2.42766830 |
| 135 | glandular epithelial cell development (GO:0002068) | 2.41929197 |
| 136 | basement membrane organization (GO:0071711) | 2.41052369 |
| 137 | * Golgi organization (GO:0007030) | 2.41025684 |
| 138 | cellular copper ion homeostasis (GO:0006878) | 2.40797217 |
| 139 | epithelial cell-cell adhesion (GO:0090136) | 2.40627266 |
| 140 | protein autoprocessing (GO:0016540) | 2.40221881 |
| 141 | maintenance of protein localization in organelle (GO:0072595) | 2.39908926 |
| 142 | nucleotide-sugar metabolic process (GO:0009225) | 2.39707253 |
| 143 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.39698299 |
| 144 | peptidyl-lysine dimethylation (GO:0018027) | 2.39431937 |
| 145 | carbohydrate derivative transport (GO:1901264) | 2.39103524 |
| 146 | sphingosine metabolic process (GO:0006670) | 2.38819574 |
| 147 | tricarboxylic acid cycle (GO:0006099) | 2.37759675 |
| 148 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.36638689 |
| 149 | collagen fibril organization (GO:0030199) | 2.36146955 |
| 150 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.36132299 |
| 151 | axis elongation (GO:0003401) | 2.34375218 |
| 152 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.33979510 |
| 153 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.32879773 |
| 154 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.32543972 |
| 155 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.32305480 |
| 156 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.31359110 |
| 157 | biotin metabolic process (GO:0006768) | 2.30781664 |
| 158 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29895924 |
| 159 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.28896065 |
| 160 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.28747472 |
| 161 | positive regulation of hormone metabolic process (GO:0032352) | 2.28738327 |
| 162 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.28130102 |
| 163 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.27991057 |
| 164 | protein carboxylation (GO:0018214) | 2.27991057 |
| 165 | extracellular regulation of signal transduction (GO:1900115) | 2.25204766 |
| 166 | extracellular negative regulation of signal transduction (GO:1900116) | 2.25204766 |
| 167 | type B pancreatic cell proliferation (GO:0044342) | 2.25129150 |
| 168 | lipid particle organization (GO:0034389) | 2.25067532 |
| 169 | proline biosynthetic process (GO:0006561) | 2.24637638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.46106176 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.37707093 |
| 3 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.26848971 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98778397 |
| 5 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.75894093 |
| 6 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.56842235 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.56215289 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.55153367 |
| 9 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.53530550 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.52663931 |
| 11 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.47097189 |
| 12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.45380072 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37624561 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34323693 |
| 15 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.30154984 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.21129314 |
| 17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.16249069 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15714002 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.14495175 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.08209895 |
| 21 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.04567936 |
| 22 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.01357588 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01300601 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00917466 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.00290795 |
| 26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.99398477 |
| 27 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.97084989 |
| 28 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.94439326 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.76656937 |
| 30 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.74313859 |
| 31 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.74313859 |
| 32 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.71282834 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66573394 |
| 34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.66009181 |
| 35 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64532616 |
| 36 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63254402 |
| 37 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.63145745 |
| 38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.62986096 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62751449 |
| 40 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62646644 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.59956427 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59377238 |
| 43 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56809139 |
| 44 | CJUN_26792858_Chip-Seq_BT549_Human | 1.56132512 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.51865538 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.50554982 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.49646102 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.49087134 |
| 49 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.48164571 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46973477 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.46122584 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45230632 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.44642416 |
| 54 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44527927 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44251247 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41993811 |
| 57 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40830271 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39639113 |
| 59 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38414524 |
| 60 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.37136255 |
| 61 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36888110 |
| 62 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35325883 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34466526 |
| 64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.34243134 |
| 65 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33841129 |
| 66 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.33415186 |
| 67 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.33296322 |
| 68 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.32941369 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.32080521 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32008950 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31069549 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.30517717 |
| 73 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30395353 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28090093 |
| 75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27623123 |
| 76 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27538944 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27429106 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.26649846 |
| 79 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.26612032 |
| 80 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25615597 |
| 81 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25615597 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24373999 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24075886 |
| 84 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.22842052 |
| 85 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22085645 |
| 86 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21856659 |
| 87 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.20223893 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19885421 |
| 89 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19708942 |
| 90 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18588012 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18568305 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18568305 |
| 93 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18544822 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18337494 |
| 95 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17713853 |
| 96 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.17503288 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17106133 |
| 98 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16955958 |
| 99 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.15868186 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14753501 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14646630 |
| 102 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14037888 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14022789 |
| 104 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.12672873 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12667913 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12231278 |
| 107 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11911509 |
| 108 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10403691 |
| 109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10156576 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09631050 |
| 111 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08911915 |
| 112 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08847173 |
| 113 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08110391 |
| 114 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.07849310 |
| 115 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07444402 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07105990 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06997353 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.06916594 |
| 119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06625069 |
| 120 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06593655 |
| 121 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06101989 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.05891602 |
| 123 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04714733 |
| 124 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04555781 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04186388 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03994270 |
| 127 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03424231 |
| 128 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03277553 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03090162 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02694777 |
| 131 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02550174 |
| 132 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01091333 |
| 133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01025073 |
| 134 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.00956224 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00715349 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.00396007 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00080905 |
| 138 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.99543324 |
| 139 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98577615 |
| 140 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98431873 |
| 141 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97993734 |
| 142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97645714 |
| 143 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97402404 |
| 144 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97058944 |
| 145 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96346549 |
| 146 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95211805 |
| 147 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93786238 |
| 148 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92584754 |
| 149 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92241618 |
| 150 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91473685 |
| 151 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91250635 |
| 152 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.91187442 |
| 153 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.91119625 |
| 154 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89977453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.55263735 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.49891210 |
| 3 | MP0003195_calcinosis | 3.66947449 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.18832493 |
| 5 | MP0006054_spinal_hemorrhage | 3.18460628 |
| 6 | MP0004043_abnormal_pH_regulation | 3.02176509 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.97998882 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.76487242 |
| 9 | MP0003941_abnormal_skin_development | 2.75259515 |
| 10 | MP0000566_synostosis | 2.60351518 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.59099945 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.57602572 |
| 13 | MP0000920_abnormal_myelination | 2.54272439 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.53880652 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.48097733 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.43962864 |
| 17 | MP0002693_abnormal_pancreas_physiology | 2.24920367 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.23675246 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.14014992 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.09111024 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.02551206 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.96556587 |
| 23 | MP0001944_abnormal_pancreas_morphology | 1.94884774 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.93236494 |
| 25 | MP0004272_abnormal_basement_membrane | 1.80529782 |
| 26 | MP0003690_abnormal_glial_cell | 1.80335672 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.79199522 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.71064200 |
| 29 | MP0005408_hypopigmentation | 1.70398670 |
| 30 | MP0003186_abnormal_redox_activity | 1.66804798 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.66388026 |
| 32 | MP0002933_joint_inflammation | 1.65143276 |
| 33 | MP0001542_abnormal_bone_strength | 1.60797472 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.59922305 |
| 35 | MP0002796_impaired_skin_barrier | 1.59159099 |
| 36 | MP0000462_abnormal_digestive_system | 1.58725939 |
| 37 | MP0009840_abnormal_foam_cell | 1.58350824 |
| 38 | MP0005379_endocrine/exocrine_gland_phen | 1.57408890 |
| 39 | MP0000467_abnormal_esophagus_morphology | 1.55692664 |
| 40 | MP0003868_abnormal_feces_composition | 1.54103032 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.53096731 |
| 42 | MP0002295_abnormal_pulmonary_circulatio | 1.51573677 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.50245850 |
| 44 | MP0005083_abnormal_biliary_tract | 1.49737055 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.46861577 |
| 46 | MP0002896_abnormal_bone_mineralization | 1.40185476 |
| 47 | MP0005365_abnormal_bile_salt | 1.40091681 |
| 48 | MP0005503_abnormal_tendon_morphology | 1.39099879 |
| 49 | MP0004134_abnormal_chest_morphology | 1.34242817 |
| 50 | MP0000627_abnormal_mammary_gland | 1.31357650 |
| 51 | MP0001756_abnormal_urination | 1.30968441 |
| 52 | MP0003283_abnormal_digestive_organ | 1.29996756 |
| 53 | MP0005248_abnormal_Harderian_gland | 1.29574551 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.27617585 |
| 55 | MP0000377_abnormal_hair_follicle | 1.26497328 |
| 56 | MP0001915_intracranial_hemorrhage | 1.25695654 |
| 57 | MP0000613_abnormal_salivary_gland | 1.25213993 |
| 58 | MP0003634_abnormal_glial_cell | 1.23410066 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.23191499 |
| 60 | MP0003724_increased_susceptibility_to | 1.23070434 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.22076350 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.21828014 |
| 63 | MP0005501_abnormal_skin_physiology | 1.21036225 |
| 64 | MP0003795_abnormal_bone_structure | 1.20998823 |
| 65 | MP0005623_abnormal_meninges_morphology | 1.19928870 |
| 66 | MP0005275_abnormal_skin_tensile | 1.17432017 |
| 67 | MP0006082_CNS_inflammation | 1.14059938 |
| 68 | MP0003091_abnormal_cell_migration | 1.13786014 |
| 69 | MP0005310_abnormal_salivary_gland | 1.13057923 |
| 70 | MP0004019_abnormal_vitamin_homeostasis | 1.12570824 |
| 71 | MP0002419_abnormal_innate_immunity | 1.12423279 |
| 72 | MP0002090_abnormal_vision | 1.12318532 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.12275379 |
| 74 | MP0000762_abnormal_tongue_morphology | 1.10537527 |
| 75 | MP0001216_abnormal_epidermal_layer | 1.08519951 |
| 76 | MP0001849_ear_inflammation | 1.07037870 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.05687912 |
| 78 | MP0005390_skeleton_phenotype | 1.05653043 |
| 79 | MP0005171_absent_coat_pigmentation | 1.04857283 |
| 80 | MP0003011_delayed_dark_adaptation | 1.03913736 |
| 81 | MP0001765_abnormal_ion_homeostasis | 1.03390189 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.02084204 |
| 83 | MP0001661_extended_life_span | 1.01400807 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 1.01202988 |
| 85 | MP0001958_emphysema | 0.98058203 |
| 86 | MP0003436_decreased_susceptibility_to | 0.97766192 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.97552890 |
| 88 | MP0000604_amyloidosis | 0.97518532 |
| 89 | MP0000343_altered_response_to | 0.97239772 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.96717025 |
| 91 | MP0002009_preneoplasia | 0.96540330 |
| 92 | MP0005508_abnormal_skeleton_morphology | 0.96431598 |
| 93 | MP0003329_amyloid_beta_deposits | 0.95727392 |
| 94 | MP0000534_abnormal_ureter_morphology | 0.95716931 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.95491323 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.94694417 |
| 97 | MP0000579_abnormal_nail_morphology | 0.91861834 |
| 98 | MP0004233_abnormal_muscle_weight | 0.90838032 |
| 99 | MP0003115_abnormal_respiratory_system | 0.89951639 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.89921904 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.89779362 |
| 102 | MP0003959_abnormal_lean_body | 0.87941356 |
| 103 | MP0005164_abnormal_response_to | 0.87175386 |
| 104 | MP0000163_abnormal_cartilage_morphology | 0.86284007 |
| 105 | MP0001881_abnormal_mammary_gland | 0.85429273 |
| 106 | MP0010771_integument_phenotype | 0.84525040 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.84040189 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.83901961 |
| 109 | MP0005409_darkened_coat_color | 0.83866398 |
| 110 | MP0010678_abnormal_skin_adnexa | 0.83581447 |
| 111 | MP0004858_abnormal_nervous_system | 0.83473736 |
| 112 | MP0001879_abnormal_lymphatic_vessel | 0.83444736 |
| 113 | MP0008004_abnormal_stomach_pH | 0.83235690 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.82989573 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.82449431 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.82240373 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.81287254 |
| 118 | MP0000537_abnormal_urethra_morphology | 0.79962869 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.79437274 |
| 120 | MP0005375_adipose_tissue_phenotype | 0.79244819 |
| 121 | MP0001851_eye_inflammation | 0.78746141 |
| 122 | MP0000383_abnormal_hair_follicle | 0.78368410 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.77998576 |
| 124 | MP0005000_abnormal_immune_tolerance | 0.77930686 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.77881518 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.77452938 |
| 127 | MP0005332_abnormal_amino_acid | 0.77148909 |
| 128 | MP0005085_abnormal_gallbladder_physiolo | 0.76484255 |
| 129 | MP0005451_abnormal_body_composition | 0.75528960 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.74475817 |
| 131 | MP0003279_aneurysm | 0.74026273 |
| 132 | MP0000767_abnormal_smooth_muscle | 0.73515744 |
| 133 | MP0002060_abnormal_skin_morphology | 0.72032219 |
| 134 | MP0005023_abnormal_wound_healing | 0.70335896 |
| 135 | MP0008469_abnormal_protein_level | 0.69371583 |
| 136 | MP0002168_other_aberrant_phenotype | 0.68420383 |
| 137 | MP0001243_abnormal_dermal_layer | 0.68244138 |
| 138 | MP0001986_abnormal_taste_sensitivity | 0.68076281 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.67960310 |
| 140 | MP0003866_abnormal_defecation | 0.66337033 |
| 141 | MP0001664_abnormal_digestion | 0.65544333 |
| 142 | MP0005165_increased_susceptibility_to | 0.64359813 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.63971252 |
| 144 | MP0005330_cardiomyopathy | 0.63601670 |
| 145 | MP0001790_abnormal_immune_system | 0.63355211 |
| 146 | MP0005387_immune_system_phenotype | 0.63355211 |
| 147 | MP0000432_abnormal_head_morphology | 0.63051430 |
| 148 | MP0002115_abnormal_skeleton_extremities | 0.62804723 |
| 149 | MP0002139_abnormal_hepatobiliary_system | 0.62610124 |
| 150 | MP0005193_abnormal_anterior_eye | 0.62189822 |
| 151 | MP0009053_abnormal_anal_canal | 0.61453415 |
| 152 | MP0006072_abnormal_retinal_apoptosis | 0.60756563 |
| 153 | MP0002697_abnormal_eye_size | 0.60236054 |
| 154 | MP0000647_abnormal_sebaceous_gland | 0.60044428 |
| 155 | MP0009697_abnormal_copulation | 0.59547004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 4.95561661 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.62208267 |
| 3 | Hypoglycemic coma (HP:0001325) | 4.15760148 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.98526549 |
| 5 | Mucopolysacchariduria (HP:0008155) | 3.85327389 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.85327389 |
| 7 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.68655250 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.66863172 |
| 9 | Hypoglycemic seizures (HP:0002173) | 3.65952382 |
| 10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.62032947 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.57864239 |
| 12 | Right ventricular cardiomyopathy (HP:0011663) | 3.53226018 |
| 13 | Symptomatic seizures (HP:0011145) | 3.52237419 |
| 14 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45098547 |
| 15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.32566247 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.32566247 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.32566247 |
| 18 | Vascular tortuosity (HP:0004948) | 3.21898243 |
| 19 | Generalized aminoaciduria (HP:0002909) | 3.17195636 |
| 20 | Atrophic scars (HP:0001075) | 3.15525970 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.13138356 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.13138356 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.13138356 |
| 24 | Vertebral compression fractures (HP:0002953) | 3.10627889 |
| 25 | Epiphyseal dysplasia (HP:0002656) | 3.09301169 |
| 26 | Mitral stenosis (HP:0001718) | 3.06893634 |
| 27 | Arterial tortuosity (HP:0005116) | 3.05189825 |
| 28 | Beaking of vertebral bodies (HP:0004568) | 3.02936392 |
| 29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.97207004 |
| 30 | Progressive neurologic deterioration (HP:0002344) | 2.94561164 |
| 31 | Asymmetry of the thorax (HP:0001555) | 2.92116234 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.92007668 |
| 33 | Large for gestational age (HP:0001520) | 2.85922771 |
| 34 | Fat malabsorption (HP:0002630) | 2.80699513 |
| 35 | Vascular calcification (HP:0004934) | 2.79733045 |
| 36 | Abnormal pancreas size (HP:0012094) | 2.79195947 |
| 37 | Neurofibrillary tangles (HP:0002185) | 2.76309652 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.71201976 |
| 39 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.69726791 |
| 40 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.69726791 |
| 41 | Abnormal protein glycosylation (HP:0012346) | 2.69726791 |
| 42 | Abnormal glycosylation (HP:0012345) | 2.69726791 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 2.66996093 |
| 44 | Protuberant abdomen (HP:0001538) | 2.66434054 |
| 45 | Aortic dissection (HP:0002647) | 2.66166792 |
| 46 | Abnormality of dentin (HP:0010299) | 2.64675549 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.63956021 |
| 48 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.63956021 |
| 49 | Short nail (HP:0001799) | 2.62246332 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.61997850 |
| 51 | Cervical subluxation (HP:0003308) | 2.56692891 |
| 52 | Flat acetabular roof (HP:0003180) | 2.43040921 |
| 53 | Abnormal tarsal ossification (HP:0008369) | 2.41400901 |
| 54 | Wormian bones (HP:0002645) | 2.41084624 |
| 55 | Delayed epiphyseal ossification (HP:0002663) | 2.37489523 |
| 56 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.35961015 |
| 57 | Spondylolisthesis (HP:0003302) | 2.34399298 |
| 58 | Hyperglycemia (HP:0003074) | 2.34157825 |
| 59 | Disproportionate short-trunk short stature (HP:0003521) | 2.33285880 |
| 60 | Autoamputation (HP:0001218) | 2.31667982 |
| 61 | Retinal atrophy (HP:0001105) | 2.29273586 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.28418811 |
| 63 | Ketoacidosis (HP:0001993) | 2.28245963 |
| 64 | Menstrual irregularities (HP:0000858) | 2.27997073 |
| 65 | Microglossia (HP:0000171) | 2.26939954 |
| 66 | Ovoid vertebral bodies (HP:0003300) | 2.25414860 |
| 67 | Abnormal foot bone ossification (HP:0010675) | 2.25401178 |
| 68 | Hypoplasia of the odontoid process (HP:0003311) | 2.23860357 |
| 69 | Pterygium (HP:0001059) | 2.23551745 |
| 70 | Back pain (HP:0003418) | 2.22403271 |
| 71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21165716 |
| 72 | Abnormality of carpal bone ossification (HP:0006257) | 2.21043281 |
| 73 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.20737366 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.20243283 |
| 75 | Irregular vertebral endplates (HP:0003301) | 2.19347369 |
| 76 | Ankle contracture (HP:0006466) | 2.18034471 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.15794434 |
| 78 | Thoracolumbar scoliosis (HP:0002944) | 2.15146041 |
| 79 | Abnormality of macrophages (HP:0004311) | 2.12308888 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.10975902 |
| 81 | Small epiphyses (HP:0010585) | 2.09815229 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.09565768 |
| 83 | Nonimmune hydrops fetalis (HP:0001790) | 2.08237797 |
| 84 | Abdominal distention (HP:0003270) | 2.07700296 |
| 85 | Pheochromocytoma (HP:0002666) | 2.07325311 |
| 86 | Hypokalemia (HP:0002900) | 2.07165524 |
| 87 | Metaphyseal irregularity (HP:0003025) | 2.06630656 |
| 88 | Fragile skin (HP:0001030) | 2.05479009 |
| 89 | Hyperparathyroidism (HP:0000843) | 2.05162113 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.04726502 |
| 91 | Hypokinesia (HP:0002375) | 2.04429974 |
| 92 | Platyspondyly (HP:0000926) | 2.04201865 |
| 93 | Joint stiffness (HP:0001387) | 2.04149100 |
| 94 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.03733244 |
| 95 | Axonal loss (HP:0003447) | 2.02965270 |
| 96 | Plantar hyperkeratosis (HP:0007556) | 2.01538711 |
| 97 | Papillary thyroid carcinoma (HP:0002895) | 2.00656929 |
| 98 | Poor head control (HP:0002421) | 2.00302201 |
| 99 | Flat capital femoral epiphysis (HP:0003370) | 2.00086574 |
| 100 | Testicular neoplasm (HP:0010788) | 1.98701360 |
| 101 | Pili torti (HP:0003777) | 1.98571977 |
| 102 | Late onset (HP:0003584) | 1.97707884 |
| 103 | Abnormality of the acetabulum (HP:0003170) | 1.95828297 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 1.94287721 |
| 105 | Glycosuria (HP:0003076) | 1.94287721 |
| 106 | Absent frontal sinuses (HP:0002688) | 1.93831011 |
| 107 | Barrel-shaped chest (HP:0001552) | 1.93549137 |
| 108 | Neonatal short-limb short stature (HP:0008921) | 1.92336396 |
| 109 | Myoglobinuria (HP:0002913) | 1.91846678 |
| 110 | Abnormality of the vertebral endplates (HP:0005106) | 1.91407158 |
| 111 | Abnormality of oral frenula (HP:0000190) | 1.91102944 |
| 112 | Patchy hypopigmentation of hair (HP:0011365) | 1.90199091 |
| 113 | Insidious onset (HP:0003587) | 1.89979273 |
| 114 | Termporal pattern (HP:0011008) | 1.89979273 |
| 115 | Hepatic necrosis (HP:0002605) | 1.88980493 |
| 116 | Palmoplantar hyperkeratosis (HP:0000972) | 1.88928817 |
| 117 | Tetraparesis (HP:0002273) | 1.87393366 |
| 118 | Thyroid carcinoma (HP:0002890) | 1.86361663 |
| 119 | Steatorrhea (HP:0002570) | 1.86171296 |
| 120 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86000687 |
| 121 | Popliteal pterygium (HP:0009756) | 1.85700373 |
| 122 | Follicular hyperkeratosis (HP:0007502) | 1.85008811 |
| 123 | Irregular epiphyses (HP:0010582) | 1.84757378 |
| 124 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84585381 |
| 125 | Periodontitis (HP:0000704) | 1.84303917 |
| 126 | Soft skin (HP:0000977) | 1.83439300 |
| 127 | Congenital glaucoma (HP:0001087) | 1.83432318 |
| 128 | Cerebral hypomyelination (HP:0006808) | 1.82980510 |
| 129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.82714442 |
| 130 | Abnormality of the lumbar spine (HP:0100712) | 1.82415693 |
| 131 | Conjugated hyperbilirubinemia (HP:0002908) | 1.82262323 |
| 132 | Palmar hyperkeratosis (HP:0010765) | 1.82143154 |
| 133 | Lower limb hyperreflexia (HP:0002395) | 1.81283179 |
| 134 | Enlarged epiphyses (HP:0010580) | 1.80451287 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.80410550 |
| 136 | Hypoplasia of the uterus (HP:0000013) | 1.78892543 |
| 137 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.78455966 |
| 138 | Ankyloglossia (HP:0010296) | 1.77124976 |
| 139 | Reduced antithrombin III activity (HP:0001976) | 1.76989088 |
| 140 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.76778808 |
| 141 | Abnormal delivery (HP:0001787) | 1.76732089 |
| 142 | Syringomyelia (HP:0003396) | 1.76316597 |
| 143 | Spinal cord lesions (HP:0100561) | 1.76316597 |
| 144 | Exocrine pancreatic insufficiency (HP:0001738) | 1.76273450 |
| 145 | Bladder diverticulum (HP:0000015) | 1.75916012 |
| 146 | Parakeratosis (HP:0001036) | 1.75650309 |
| 147 | Hypokalemic alkalosis (HP:0001949) | 1.75622343 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.75475163 |
| 149 | Advanced eruption of teeth (HP:0006288) | 1.74842720 |
| 150 | Vertebral arch anomaly (HP:0008438) | 1.74221392 |
| 151 | Decreased circulating renin level (HP:0003351) | 1.73954857 |
| 152 | White forelock (HP:0002211) | 1.73622607 |
| 153 | Breech presentation (HP:0001623) | 1.72752410 |
| 154 | Pulmonary artery stenosis (HP:0004415) | 1.72719193 |
| 155 | Hyperammonemia (HP:0001987) | 1.71763500 |
| 156 | Episodic fever (HP:0001954) | 1.71026004 |
| 157 | J-shaped sella turcica (HP:0002680) | 1.70473599 |
| 158 | Osteolytic defects of the hand bones (HP:0009699) | 1.70240298 |
| 159 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70240298 |
| 160 | Premature skin wrinkling (HP:0100678) | 1.69997986 |
| 161 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69522082 |
| 162 | Abnormality of the odontoid process (HP:0003310) | 1.69484519 |
| 163 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.69154832 |
| 164 | Deep venous thrombosis (HP:0002625) | 1.68613703 |
| 165 | Skin nodule (HP:0200036) | 1.67217376 |
| 166 | Orthostatic hypotension (HP:0001278) | 1.66789588 |
| 167 | Spinal cord compression (HP:0002176) | 1.66526710 |
| 168 | Abnormal hand bone ossification (HP:0010660) | 1.66448844 |
| 169 | Osteoarthritis (HP:0002758) | 1.66436196 |
| 170 | Abnormal ossification of hand bones (HP:0005921) | 1.66361583 |
| 171 | Coxa vara (HP:0002812) | 1.65773402 |
| 172 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.65748584 |
| 173 | Growth hormone excess (HP:0000845) | 1.65338428 |
| 174 | Vertebral hypoplasia (HP:0008417) | 1.64747684 |
| 175 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.64747684 |
| 176 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.64449094 |
| 177 | Hyperphosphatemia (HP:0002905) | 1.64257926 |
| 178 | Elevated alkaline phosphatase (HP:0003155) | 1.63078691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 4.34501110 |
| 2 | ERN1 | 3.52868632 |
| 3 | STK39 | 3.23688914 |
| 4 | EPHB1 | 3.11236972 |
| 5 | MKNK1 | 2.87370812 |
| 6 | MAPK15 | 2.85235785 |
| 7 | TAOK3 | 2.82709919 |
| 8 | MST4 | 2.79597028 |
| 9 | INSRR | 2.64872395 |
| 10 | WNK4 | 2.56399766 |
| 11 | PASK | 2.50745081 |
| 12 | PDGFRA | 2.44792613 |
| 13 | MET | 2.34807304 |
| 14 | IRAK3 | 2.30772838 |
| 15 | PBK | 2.22314980 |
| 16 | BCKDK | 2.21619870 |
| 17 | MAP3K12 | 2.21439709 |
| 18 | LATS1 | 2.18252840 |
| 19 | EIF2AK3 | 2.07945349 |
| 20 | LIMK1 | 2.01461096 |
| 21 | FER | 1.90192879 |
| 22 | PKN2 | 1.83921543 |
| 23 | MAP3K3 | 1.80915466 |
| 24 | MAP3K2 | 1.76896820 |
| 25 | FGFR4 | 1.74308072 |
| 26 | TAOK2 | 1.72749178 |
| 27 | IRAK4 | 1.70543992 |
| 28 | STK38L | 1.66599876 |
| 29 | TESK1 | 1.66343040 |
| 30 | PIK3CG | 1.65963914 |
| 31 | MAPKAPK3 | 1.48970612 |
| 32 | HIPK2 | 1.48278614 |
| 33 | TAOK1 | 1.42444827 |
| 34 | MAP2K2 | 1.41410585 |
| 35 | OXSR1 | 1.40636363 |
| 36 | ERBB4 | 1.39642332 |
| 37 | LMTK2 | 1.38546472 |
| 38 | MAPKAPK5 | 1.37222411 |
| 39 | PIM2 | 1.35968284 |
| 40 | FGFR3 | 1.35365027 |
| 41 | EIF2AK1 | 1.33020830 |
| 42 | BRSK2 | 1.30228576 |
| 43 | FRK | 1.27206053 |
| 44 | LATS2 | 1.26596060 |
| 45 | NEK1 | 1.25048545 |
| 46 | SCYL2 | 1.25022303 |
| 47 | RIPK1 | 1.24489153 |
| 48 | BCR | 1.24435924 |
| 49 | NTRK1 | 1.21327954 |
| 50 | NEK6 | 1.19827558 |
| 51 | TESK2 | 1.18439446 |
| 52 | PRKD3 | 1.17634141 |
| 53 | STK24 | 1.17622261 |
| 54 | TRPM7 | 1.13913727 |
| 55 | IRAK1 | 1.11600328 |
| 56 | EEF2K | 1.10855977 |
| 57 | NME2 | 1.07213088 |
| 58 | TRIB3 | 1.03649526 |
| 59 | FLT3 | 1.03459282 |
| 60 | EPHA3 | 0.98715843 |
| 61 | EPHA2 | 0.98105023 |
| 62 | CDK6 | 0.96687994 |
| 63 | UHMK1 | 0.96446474 |
| 64 | SRPK1 | 0.96059072 |
| 65 | KDR | 0.93671804 |
| 66 | JAK1 | 0.92683294 |
| 67 | LRRK2 | 0.92171171 |
| 68 | PTK6 | 0.91497121 |
| 69 | ZAP70 | 0.89072915 |
| 70 | ARAF | 0.88534489 |
| 71 | SIK1 | 0.87522698 |
| 72 | TTK | 0.85053486 |
| 73 | MYLK | 0.84955857 |
| 74 | BUB1 | 0.82495303 |
| 75 | BMPR1B | 0.80377254 |
| 76 | CSNK1A1L | 0.79615944 |
| 77 | STK3 | 0.78666722 |
| 78 | YES1 | 0.78568969 |
| 79 | CLK1 | 0.78155232 |
| 80 | NEK9 | 0.78046938 |
| 81 | RPS6KB2 | 0.74658541 |
| 82 | PTK2 | 0.73791078 |
| 83 | CSNK1G3 | 0.72938322 |
| 84 | CAMK2D | 0.72726170 |
| 85 | PAK3 | 0.72435502 |
| 86 | RET | 0.72243388 |
| 87 | PDGFRB | 0.71575208 |
| 88 | STK16 | 0.69786467 |
| 89 | MST1R | 0.69705134 |
| 90 | TTN | 0.69401441 |
| 91 | TBK1 | 0.69220697 |
| 92 | IRAK2 | 0.68104606 |
| 93 | ITK | 0.67651294 |
| 94 | NUAK1 | 0.66551878 |
| 95 | FGFR2 | 0.64968819 |
| 96 | ABL2 | 0.63318623 |
| 97 | MAP2K3 | 0.63241271 |
| 98 | MAP3K1 | 0.62706054 |
| 99 | PRKG2 | 0.62452676 |
| 100 | ILK | 0.61905769 |
| 101 | AKT3 | 0.60684895 |
| 102 | TGFBR2 | 0.59670997 |
| 103 | FGFR1 | 0.59456199 |
| 104 | WNK1 | 0.58996492 |
| 105 | CSK | 0.56020101 |
| 106 | CSNK1G1 | 0.54051709 |
| 107 | EPHB2 | 0.53188970 |
| 108 | PRKD1 | 0.53052114 |
| 109 | BTK | 0.52836502 |
| 110 | MAPKAPK2 | 0.52260882 |
| 111 | NLK | 0.51150818 |
| 112 | GSK3A | 0.49977401 |
| 113 | TEC | 0.49620824 |
| 114 | CAMKK2 | 0.49467168 |
| 115 | DDR2 | 0.48883875 |
| 116 | PRKCE | 0.46408576 |
| 117 | PDK2 | 0.45104600 |
| 118 | ERBB3 | 0.44991131 |
| 119 | TSSK6 | 0.44578743 |
| 120 | PIK3CA | 0.43954398 |
| 121 | TYK2 | 0.41235924 |
| 122 | MAP3K8 | 0.41229366 |
| 123 | MAP3K5 | 0.39290677 |
| 124 | PHKG2 | 0.39069340 |
| 125 | PHKG1 | 0.39069340 |
| 126 | PKN1 | 0.38526552 |
| 127 | IGF1R | 0.38276506 |
| 128 | PAK1 | 0.38265425 |
| 129 | CDC42BPA | 0.37950693 |
| 130 | BLK | 0.37696376 |
| 131 | ROCK2 | 0.37504907 |
| 132 | PAK2 | 0.36775032 |
| 133 | CSNK1A1 | 0.36449335 |
| 134 | RPS6KB1 | 0.35994371 |
| 135 | PAK4 | 0.35983731 |
| 136 | CAMK2G | 0.35914902 |
| 137 | KSR2 | 0.35483738 |
| 138 | RPS6KA5 | 0.35449303 |
| 139 | MUSK | 0.35398190 |
| 140 | STK10 | 0.34235905 |
| 141 | BRAF | 0.34177317 |
| 142 | WNK3 | 0.34125248 |
| 143 | ICK | 0.34091434 |
| 144 | JAK3 | 0.33776201 |
| 145 | DYRK1B | 0.32967679 |
| 146 | STK38 | 0.32110756 |
| 147 | PRKCH | 0.31165661 |
| 148 | AKT2 | 0.30681511 |
| 149 | DYRK1A | 0.28661257 |
| 150 | SRC | 0.26222772 |
| 151 | ACVR1B | 0.26074696 |
| 152 | MTOR | 0.25944541 |
| 153 | MAP3K6 | 0.24857777 |
| 154 | SMG1 | 0.24689447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 7.27529260 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.84176515 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.62511975 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.30336376 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.81061363 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.63140110 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.59386874 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.55334386 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.39122127 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.25629026 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.17141342 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.99589737 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84957518 |
| 14 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.73677186 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.66816309 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.60282703 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.56348450 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55867483 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.55680036 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.51760446 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46533546 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.43358408 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.40405070 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39563620 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35461615 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34223950 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.33404876 |
| 28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.29160835 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26839767 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23174895 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23080744 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21537563 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20220193 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20159407 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18761442 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16040226 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.15039378 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15007786 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14059199 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.13856427 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13823446 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12886877 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12487785 |
| 44 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11143764 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.09152503 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07566460 |
| 47 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98184888 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97427563 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96215546 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96006926 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95972295 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94996440 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94717737 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93251289 |
| 55 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92636397 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.91136588 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90822645 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89314715 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86256575 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.85279330 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85101105 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84317198 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84221698 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80993599 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.80909647 |
| 66 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80349678 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79885632 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.77295571 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.77102769 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76159276 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75220682 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74595544 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74289061 |
| 74 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72753990 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.69840295 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69290103 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69282438 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68099758 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.66912211 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66616347 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65840163 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65735317 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.64186839 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64142786 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63114576 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62445622 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62173553 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.58448093 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57647806 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57605672 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57363277 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54684098 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54217576 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54160784 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53308347 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53034887 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52998945 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50926263 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.50613195 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.49581447 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49033401 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47952252 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46265763 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.44452831 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.43228997 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.42784554 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39777274 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39126487 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.38965614 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38286796 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37419752 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36220076 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34939841 |
| 114 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34832481 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32975319 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.31976526 |
| 117 | Tight junction_Homo sapiens_hsa04530 | 0.31387733 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.31327659 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.30545663 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.30508404 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.30032318 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28208051 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27004938 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.26685089 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24963079 |
| 126 | RNA polymerase_Homo sapiens_hsa03020 | 0.24091157 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.22750792 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20929095 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19923932 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.19887591 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.19134172 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.17919058 |
| 133 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.17164390 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17086045 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.16668552 |
| 136 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16539981 |
| 137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16437877 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.14900598 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.14573069 |

